This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07295/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07295/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB07295/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07295/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07295/identifier/chemspider/

Statements

Subject Item
n2:DB07295
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n11:DB07295 n14:DB07295
dcterms:title
2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID
adms:identifier
n4:394714 n7:447695 n8:99443766 n12:DB07295 n13:968
n5:IUPAC-Name
n6:271B5D53-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5D59-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5D58-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5D55-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5D56-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5D57-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5D51-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5D4F-363D-11E5-9242-09173F13E4C5 n6:271B5D52-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5D50-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5D5F-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5D60-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5D5A-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5D5B-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5D5D-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5D5C-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5D5E-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5D65-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5D67-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5D68-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5D64-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5D63-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5D66-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5D54-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5D61-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5D62-363D-11E5-9242-09173F13E4C5